Comparison of K-doped and pure cold-rolled tungsten sheets: As-rolled condition and recrystallization behaviour after isochronal annealing at different temperatures

Severely deformed cold-rolled tungsten is a promising structural material for future fusion reactor applications due to high melting temperature and excellent mechanical properties. However, the fine-grained microstructure after deformation is not stable at temperatures above 800 °C, leading to brittle material behaviour. In this study, we utilize potassium-doping to inhibit recrystallization of tungsten sheets, a mechanism well known from incandescent lamp wires. We produced K-doped tungsten sheets by warm-rolling and subsequent cold-rolling with five different logarithmic strains up to 4.6, and equivalently rolled pure tungsten sheets. Both sets of materials are compared using EBSD and microhardness testing. In both materials, the hardness increases and the grain size along normal direction decreases with strain; the densities of low and high angle boundaries increase in particular during cold-rolling. The K-doped W sheet reaches the highest hardness with 772 ± 8 HV0.1, compared to the pure W sheet with 711 ± 14 HV0.1. All boundaries taken into account, a Hall-Petch relation describes the hardness evolution nicely, except a deviation of the K-doped tungsten sheet rolled to highest strain with its much higher hardness. The similar structural and mechanical properties of both materials in the as-rolled condition allow further studies of recrystallization behaviour of the new K-doped material with a benchmark against the equivalent pure tungsten sheets. Isochronal annealing for 1 h was performed at different temperatures between 700 °C and 2200 °C. A sharp decrease in hardness to intermediate values is observed at around 900 °C for both materials, presumably reflecting extended recovery. A second decrease is observed at 1400 °C for pure tungsten, approaching the hardness of a single crystal and indicating recrystallization and severe growth of grains. For K-doped tungsten, however, the occurrence of the second decrease is shifted to higher temperatures from 1400 °C to 1800 °C with increasing strain and an intermediate hardness is maintained up to 1800 °C. We refer this dependence of the recrystallization resistance on strain in the K-doped material to the dispersion of K-bubbles, resulting in increased Zener pinning forces retarding boundary motion

Topical inflammasome inhibition with disulfiram prevents irritant contact dermatitis

BACKGROUND: The pathogenesis of contact dermatitis, a common inflammatory skin disease with limited treatment options, is held to be driven by inflammasome activation induced by allergens and irritants. We here aim to identify inflammasome-targeting treatment strategies for irritant contact dermatitis. METHODS: A high content screen with 41,184 small molecules was performed using fluorescent Apoptosis associated speck-like protein containing a CARD (ASC) speck formation as a readout for inflammasome activation. Hit compounds were validated for inhibition of interleukin (IL)-1β secretion. Of these, the approved thiuramdisulfide derivative disulfiram was selected and tested in a patch test model of irritant contact dermatitis in 25 healthy volunteers. Topical application of disulfiram, mometasone or vehicle was followed by application of sodiumdodecylsulfate (SDS) for 24 h each. Eczema induction was quantified by mexameter and laser speckle imaging. Corneocyte sampling of lesional skin was performed to assess inflammasome-mediated cytokines IL-1β and IL-18. RESULTS: Disulfiram induced a dose-dependent inhibition of ASC speck formation and IL-1β release in cellular assays in vitro. In vivo, treatment with disulfiram, but not with vehicle and less mometasone, inhibited SDS-induced eczema. This was demonstrated by significantly lower erythema and total perfusion values assessed by mexameter and laser speckle imaging for disulfiram compared to vehicle (p < 0.001) and/or mometasone (p < 0.001). Also, corneocyte IL-18 levels were significantly reduced after application of disulfiram compared to vehicle (p < 0.001). CONCLUSION: We show that disulfiram is a dose-dependent inhibitor of inflammasome pathway activation in vitro and inhibitor of SDS-induced eczema in vivo. Topical application of disulfiram represents a potential treatment option for irritant contact dermatitis